A Long-Term, Open-Label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia.

Trial Profile

A Long-Term, Open-Label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Acotiamide (Primary)
  • Indications Non-ulcer dyspepsia
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top